for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zhejiang Shapuaisi Pharmaceutical Co Ltd

603168.SS

Latest Trade

8.79CNY

Change

0.14(+1.62%)

Volume

1,713,033

Today's Range

8.53

 - 

8.82

52 Week Range

6.78

 - 

11.10

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.65
Open
8.63
Volume
1,713,033
3M AVG Volume
116.41
Today's High
8.82
Today's Low
8.53
52 Week High
11.10
52 Week Low
6.78
Shares Out (MIL)
322.59
Market Cap (MIL)
2,854.94
Forward P/E
--
Dividend (Yield %)
0.12

Next Event

Q3 2020 Zhejiang Shapuaisi Pharmaceutical Co Ltd Earnings Release

Latest Developments

更多

Zhejiang Shapuaisi Pharmaceutical Plans To Buy Hospital For 502 Mln Yuan

Zhejiang Shapuaisi Pharmaceutical's Shareholder Plans To Unload Up To 2% Stake In The Company

Zhejiang Shapuaisi Pharmaceutical's Controlling Shareholder Set To Change

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zhejiang Shapuaisi Pharmaceutical Co Ltd

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.

Industry

Biotechnology & Drugs

Contact Info

Lumianjin Bridge

Chengbei Road, Pinghu City

JIAXING, ZHJ

314200

China

+86.573.85021168

http://www.zjspas.com/

Executive Leadership

De Kang Chen

Chairman of the Board

Qunyan Zhang

Chief Financial Officer

Youkun Wang

General Manager, Director

Jianguo Wu

Deputy General Manager, Secretary of the Board

Zheng Guo Hu

Deputy General Manager, Director, Chief Engineer

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
7.33
Price To Book (MRQ)
1.94
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-2.17
Return on Equity (TTM)
-2.04

Latest News

Latest News

China shares end higher on industrial profits, tech rebound

China shares closed higher on Thursday, lifted by new data showing industrial profits rose in July, and as tech firms resumed a rally sparked by reforms to the country's tech-heavy ChiNext board.

China stocks gain on upbeat industrial data, tech bounce

Chinese shares rose on Thursday, boosted by technology shares, as data showed faster growth at industrial firms in July in a sign of a firming economic recovery from the coronavirus-driven slump. ** Profits at China's industrial firms grew for a third straight month in July...

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up